Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01566383 · ClinicalTrials.gov registry record · NA
Assessing Normal Multichannel Intraluminal Impedance (MII)-pH Parameters for Today's Population
A NA study, sponsored by Vanderbilt University Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT01566383 is a NA study that was terminated before completion, run by Vanderbilt University Medical Center. The registered enrollment target is 19 participants.
The verdict
NCT01566383, a NA study, was terminated before completion, sponsored by Vanderbilt University Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The normal values of a Multichannel Intraluminal Impedance (MII)-pH study can vary between ages, gender, race and different values of body mass index (BMI). This fact can cause new modifications in the normal values such as making new scales for different age groups or BMI groups. Our aim is to find the normal esophageal MII-pH parameter ranges in volunteers who never experienced reflux related symptoms and are in between the same ranges of age and BMI of our gastroesophageal reflux disease (GERD) patient population.
Interventions
- PROCEDURE 24-hr pH monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-08-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01566383
The ClinicalTrials.gov registry entry for NCT01566383 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 24-hr pH monitoring is the first listed.
NCT01566383 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01566383 about?
NCT01566383 is a clinical study titled "Assessing Normal Multichannel Intraluminal Impedance (MII)-pH Parameters for Today's Population". The normal values of a Multichannel Intraluminal Impedance (MII)-pH study can vary between ages, gender, race and different values of body mass index (BMI). This fact can cause new modifications in the normal values such as making new scales for different age groups or BMI groups. Our aim is to fin...
What is the current status of trial NCT01566383?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2012-03. Estimated completion is 2013-08-27.
What interventions are being tested in trial NCT01566383?
The interventions under investigation include: 24-hr pH monitoring (PROCEDURE).
Who is sponsoring clinical trial NCT01566383?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.